Oscar Health vs Trupanion
OSCR and TRUP side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OSCR and TRUP compare
Oscar Health is the larger company, worth 6.1 times as much as Trupanion ($9.7B against $1.6B).
On earnings, Oscar Health is cheaper: it trades at 22.4× trailing earnings, against 68.2× for Trupanion.
Oscar Health grew revenue faster over the last twelve months (42.8% versus 11.8% for Trupanion).
Oscar Health scores higher on the StockData Score (11 against 6 for Trupanion), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OSCR | TRUP |
|---|---|---|
| Size and price | ||
| Market cap | $9.7B | $1.6B |
| Share price | $31.33 | $36.16 |
| Change, 1 year | 125% | −8.2% |
| Change, 5 years | 219% | −71.5% |
| Beta (5Y) | 2.10 | 0.05 |
| Employees | 2,305 | 1,121 |
| StockData Score | ||
| Total score | 11 (better) | 6 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 4 (better) | 0 |
| Health score | 4 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 22.4× (better) | 68.2× |
| P/S | 0.6× (better) | 1.0× |
| P/B | 4.7× | 3.9× (better) |
| EV/EBITDA | 2.4× (better) | 32.7× |
| P/FCF | 2.2× (better) | 19.3× |
| FCF yield | 45.3% (better) | 5.2% |
| Fair value | $24.56 | $22.25 |
| Margin of safety | −27.6% (better) | −62.5% |
| Growth | ||
| Revenue growth (TTM) | 42.8% (better) | 11.8% |
| Revenue growth, 5Y average | 90.8% (better) | 23.4% |
| EPS growth (TTM) | – | 104% |
| Profitability | ||
| Gross margin | – | 16.6% |
| Operating margin | 4.1% (better) | 1.6% |
| Net margin | 3.6% | – |
| FCF margin | 28.6% (better) | 5.4% |
| Return on equity | 34.3% | – |
| Return on invested capital | – | 18.9% |
| Financial health | ||
| Debt / equity | 0.21 (better) | 0.26 |
| Net debt / EBITDA | −12.35 | −7.36 |
| Interest coverage | 39.7× (better) | 2.3× |
| Current ratio | 1.08 | 1.77 (better) |
| Altman Z-score | 1.97 | 3.66 (better) |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 64.7% | 77.1% |
| Held by insiders | 20.9% | 5.7% |
| Insider net buying, 12 months | −$132M | −$3.1M (better) |
| Short interest, % of float | 6.9% | 9.5% |
Go deeper
- OSCR stock overview
- OSCR income statement
- OSCR valuation and score
- TRUP stock overview
- TRUP income statement
- TRUP valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.